RIPK1 and acute lymphoblastic leukemia: Accordingly, exposure of the BCP-ALL cell line REH to etanercept was reported to decrease BV6-mediated cell death; however, this effect was not observed in the T-ALL line Jurkat.33 Furthermore, we provide evidence that the presence of RIP1 is crucial for apoptosis induction upon BV6 treatment.